FR2819255B1 - CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT - Google Patents

CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT

Info

Publication number: FR2819255B1
Authority: FR; France
Prior art keywords: application; chemical derivatives; antitelomerase; agent; antitelomerase agent
Prior art date: 2001-01-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0100205A

Other languages

French (fr)

Other versions

FR2819255A1 (en

Inventor

Patrick Mailliet

Jean Francois Riou

Marcel Alasia

Thomas Caulfield

Gilles Doerflinger

Odile Petitgenet

Emmanuelle Renou

Jean Louis Mergny

Abdelazize Laoui

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-09

Filing date

2001-01-09

Publication date

2003-02-28

2001-01-09 Priority to FR0100205A priority Critical patent/FR2819255B1/en

2001-01-09 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

2002-01-09 Priority to PCT/FR2002/000057 priority patent/WO2002055515A1/en

2002-01-09 Priority to US10/040,370 priority patent/US6858608B2/en

2002-01-09 Priority to JP2002556184A priority patent/JP2004520350A/en

2002-01-09 Priority to CA002433723A priority patent/CA2433723A1/en

2002-01-09 Priority to MXPA03005975A priority patent/MXPA03005975A/en

2002-01-09 Priority to IL15679402A priority patent/IL156794A0/en

2002-01-09 Priority to AU2002229859A priority patent/AU2002229859B2/en

2002-01-09 Priority to EP02710956A priority patent/EP1351957A1/en

2002-07-12 Publication of FR2819255A1 publication Critical patent/FR2819255A1/en

2003-02-28 Application granted granted Critical

2003-02-28 Publication of FR2819255B1 publication Critical patent/FR2819255B1/en

2004-09-30 Priority to US10/954,808 priority patent/US7179816B2/en

2021-01-09 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR0100205A 2001-01-09 2001-01-09 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT Expired - Fee Related FR2819255B1 (en)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
FR0100205A FR2819255B1 (en)	2001-01-09	2001-01-09	CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT
EP02710956A EP1351957A1 (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent
JP2002556184A JP2004520350A (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as antitelomerase agents
CA002433723A CA2433723A1 (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent
MXPA03005975A MXPA03005975A (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent.
IL15679402A IL156794A0 (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent
PCT/FR2002/000057 WO2002055515A1 (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent
US10/040,370 US6858608B2 (en)	2001-01-09	2002-01-09	Chemical derivatives and their application as antitelomerase agents
AU2002229859A AU2002229859B2 (en)	2001-01-09	2002-01-09	Chemical derivatives and their use as anti-telomerase agent
US10/954,808 US7179816B2 (en)	2001-01-09	2004-09-30	Chemical derivatives and their application as antitelomerase agents

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0100205A FR2819255B1 (en)	2001-01-09	2001-01-09	CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT

Publications (2)

Publication Number	Publication Date
FR2819255A1 FR2819255A1 (en)	2002-07-12
FR2819255B1 true FR2819255B1 (en)	2003-02-28

Family

ID=8858610

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0100205A Expired - Fee Related FR2819255B1 (en)	2001-01-09	2001-01-09	CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT

Country Status (8)

Country	Link
EP (1)	EP1351957A1 (en)
JP (1)	JP2004520350A (en)
AU (1)	AU2002229859B2 (en)
CA (1)	CA2433723A1 (en)
FR (1)	FR2819255B1 (en)
IL (1)	IL156794A0 (en)
MX (1)	MXPA03005975A (en)
WO (1)	WO2002055515A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6887873B2 (en)	2001-03-23	2005-05-03	Aventis Pharma S.A.	Triazine derivatives and their application as antitelomerase agents
US7173032B2 (en) *	2001-09-21	2007-02-06	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
FR2850970B1 (en) *	2003-02-07	2006-07-07	Aventis Pharma Sa	CHEMICAL DERIVATIVES BINDING VERY SPECIFIC TO G-QUADRUPLEX DNA STRUCTURES AND THEIR APPLICATION AS A SPECIFIC ANTICANCER AGENT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9206768D0 (en) *	1992-03-27	1992-05-13	Jarman Michael	New compounds for use in the treatment of cancer
US5767278A (en) *	1995-10-06	1998-06-16	Geron Corporation	Telomerase inhibitors
JPH1160573A (en) *	1997-08-22	1999-03-02	Nippon Kayaku Co Ltd	Triazine derivative and telomerase inhibitor

2001
- 2001-01-09 FR FR0100205A patent/FR2819255B1/en not_active Expired - Fee Related
2002
- 2002-01-09 MX MXPA03005975A patent/MXPA03005975A/en not_active Application Discontinuation
- 2002-01-09 CA CA002433723A patent/CA2433723A1/en not_active Abandoned
- 2002-01-09 JP JP2002556184A patent/JP2004520350A/en not_active Abandoned
- 2002-01-09 AU AU2002229859A patent/AU2002229859B2/en not_active Expired - Fee Related
- 2002-01-09 IL IL15679402A patent/IL156794A0/en unknown
- 2002-01-09 EP EP02710956A patent/EP1351957A1/en not_active Withdrawn
- 2002-01-09 WO PCT/FR2002/000057 patent/WO2002055515A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1351957A1 (en)	2003-10-15
WO2002055515A1 (en)	2002-07-18
IL156794A0 (en)	2004-02-08
AU2002229859B2 (en)	2008-03-13
CA2433723A1 (en)	2002-07-18
FR2819255A1 (en)	2002-07-12
MXPA03005975A (en)	2005-02-14
JP2004520350A (en)	2004-07-08

Publication	Publication Date	Title
FR20C1039I2 (en)	2021-08-13	DERIVATIVES OF UK-2A
DE60215046D1 (en)	2006-11-09	BREAKER AND APPLICATION PROCESS
IS6858A (en)	2003-06-23	Trisol pyridine as an anti-inflammatory agent
ID30393A (en)	2001-11-29	TIENOPIRIMIDINA COMPOUNDS, MAKING AND USE OF IT
MA27001A1 (en)	2004-12-20	NOVEL SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS PHOSPHO-DIESTERASE-7 INHIBITORS
DE60204857D1 (en)	2005-08-04	Atomizer
NO20034490D0 (en)	2003-10-07	Method of composition of absorbent article for personal care
ATE555761T1 (en)	2012-05-15	ABSORBENT ARTICLE
DE60209850D1 (en)	2006-05-11	Absorbent article
DE60214783D1 (en)	2006-11-02	Absorbent article
FR2830516B1 (en)	2004-01-02	SUSPENSION OF TURBOJET
BR0201972B1 (en)	2012-09-04	amount of suspension.
DE60225452D1 (en)	2008-04-17	RECESSIBLE ABSORBENT ARTICLE
PT1250321E (en)	2006-09-29	COMPOSITION OF GLIBURIDA
ITMI20021834A1 (en)	2003-02-24	SUSPENSION OF EQUIPMENT
DE60208700D1 (en)	2006-04-06	SCHÄLGERÄT AND ASSOCIATED PROCEDURES
FI20011300A0 (en)	2001-06-19	Sprinkler
NO20041968L (en)	2004-05-11	Use of cystationin
BR0209263B1 (en)	2013-08-06	coating compositions comprising high area t carbon products
FI20010075A (en)	2002-07-13	Functional product and method
DE60233109D1 (en)	2009-09-10	RADIDENTIFICATOR LOCATION PROCESS
NO20035605D0 (en)	2003-12-16	Pediatric formulation of gatifloxacin
LU90483B1 (en)	2001-01-31	New compositions of parox-tine m-thanesulfonate
FR2819255B1 (en)	2003-02-28	CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT
DE60225446D1 (en)	2008-04-17	FLAME-PROTECTED COMPOSITION AND ARTICLES

Legal Events

Date	Code	Title	Description
2009-11-27	ST	Notification of lapse	Effective date: 20091030